Efficacy and persistence of low-dose mirabegron (25 mg) in patients with overactive bladder: analysis in a real-world urological practice.

Karina Chin Po Hsu Hung-Jen Wang Yao-Chi Chuang

Published in: International urology and nephrology (2018)

Low-dose mirabegron (25 mg) improves clinical outcomes in two-thirds of OAB patients with good safety profile and high persistence in daily urological practice. The therapeutic effect is similar between the genders.

Keyphrases

low dose
primary care
high dose
healthcare
quality improvement
physical activity
urinary tract
data analysis